{"id":"https://openalex.org/W2592298658","doi":"https://doi.org/10.18632/oncotarget.15778","title":"Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPAR\u03b3","display_name":"Molecular docking, 3D-QSAR and structural optimization on imidazo-pyridine derivatives dually targeting AT1 and PPAR\u03b3","publication_year":2017,"publication_date":"2017-02-28","ids":{"openalex":"https://openalex.org/W2592298658","doi":"https://doi.org/10.18632/oncotarget.15778","mag":"2592298658","pmid":"https://pubmed.ncbi.nlm.nih.gov/28445965","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5421955"},"language":"en","primary_location":{"id":"doi:10.18632/oncotarget.15778","doi":"https://doi.org/10.18632/oncotarget.15778","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.15778","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15778&path%5B%5D=51636","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15778&path%5B%5D=51636","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101911568","display_name":"Jun Zhang","orcid":"https://orcid.org/0000-0001-8598-3752","observed_orcids":["https://orcid.org/0000-0001-8598-3752"]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jun Zhang","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080640415","display_name":"Qingqing Hao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qing-Qing Hao","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100352179","display_name":"Xin Liu","orcid":"https://orcid.org/0000-0002-0011-6113","observed_orcids":["https://orcid.org/0000-0002-0011-6113"]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Liu","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100725903","display_name":"Zhi Jing","orcid":"https://orcid.org/0009-0004-6821-6868","observed_orcids":["https://orcid.org/0009-0004-6821-6868"]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Zhi Jing","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061470624","display_name":"Wenqing Jia","orcid":"https://orcid.org/0000-0001-9310-7728","observed_orcids":["https://orcid.org/0000-0001-9310-7728"]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wen-Qing Jia","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113748735","display_name":"Shuqing Wang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shu-Qing Wang","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102213652","display_name":"Weiren Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105139","display_name":"Tianjin Institute of Pharmaceutical Research (China)","ror":"https://ror.org/01g9y2x13","country_code":"CN","type":"company","lineage":["https://openalex.org/I4210105139"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei-Ren Xu","raw_affiliation_strings":["Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory of Molecular Design and Drug Discovery, Tianjin Institute of Pharmaceutical Research, Tianjin 300193, China","institution_ids":["https://openalex.org/I4210105139"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108255426","display_name":"Xian\u2010Chao Cheng","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xian-Chao Cheng","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5034834769","display_name":"Run\u2010Ling Wang","orcid":"https://orcid.org/0000-0003-3523-925X","observed_orcids":["https://orcid.org/0000-0003-3523-925X"]},"institutions":[{"id":"https://openalex.org/I5740404","display_name":"Tianjin Medical University","ror":"https://ror.org/02mh8wx89","country_code":"CN","type":"education","lineage":["https://openalex.org/I5740404"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Run-Ling Wang","raw_affiliation_strings":["Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Tianjin Key Laboratory on Technologies Enabling Development of Clinical Therapeutics and Diagnostics (Theranostics), School of Pharmacy, Tianjin Medical University, Tianjin 300070, China","institution_ids":["https://openalex.org/I5740404"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.2363,"has_fulltext":true,"cited_by_count":7,"citation_normalized_percentile":{"value":0.48744129,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"8","issue":"15","first_page":"25612","last_page":"25627"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T14099","display_name":"Synthesis and Characterization of Heterocyclic Compounds","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/telmisartan","display_name":"telmisartan","score":0.7620000243186951},{"id":"https://openalex.org/keywords/at1-receptor-antagonism","display_name":"AT1 receptor antagonism","score":0.8650000095367432},{"id":"https://openalex.org/keywords/dual-target-drugs","display_name":"dual-target drugs","score":0.6480000019073486},{"id":"https://openalex.org/keywords/structure-activity-relationship","display_name":"structure-activity relationship","score":0.6919999718666077},{"id":"https://openalex.org/keywords/comfa","display_name":"CoMFA","score":0.8479999899864197},{"id":"https://openalex.org/keywords/molecular-docking","display_name":"molecular docking","score":0.675000011920929},{"id":"https://openalex.org/keywords/structural-optimization","display_name":"structural optimization","score":0.5070000290870667},{"id":"https://openalex.org/keywords/antihypertensive-drugs","display_name":"antihypertensive drugs","score":0.7680000066757202},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6060000061988831},{"id":"https://openalex.org/keywords/angiotensin-ii-type-1-receptor","display_name":"angiotensin II type 1 receptor","score":0.8009999990463257},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.9100000262260437}],"concepts":[{"id":"https://openalex.org/C164126121","wikidata":"https://www.wikidata.org/wiki/Q766383","display_name":"Quantitative structure\u2013activity relationship","level":2,"score":0.7258709073066711},{"id":"https://openalex.org/C41685203","wikidata":"https://www.wikidata.org/wiki/Q1974042","display_name":"Docking (animal)","level":2,"score":0.7194413542747498},{"id":"https://openalex.org/C123915805","wikidata":"https://www.wikidata.org/wiki/Q15332826","display_name":"Angiotensin II receptor type 1","level":4,"score":0.7179380655288696},{"id":"https://openalex.org/C2779716603","wikidata":"https://www.wikidata.org/wiki/Q733186","display_name":"Telmisartan","level":3,"score":0.636122465133667},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.625572144985199},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.5953153967857361},{"id":"https://openalex.org/C187345961","wikidata":"https://www.wikidata.org/wiki/Q419629","display_name":"Peroxisome proliferator-activated receptor","level":3,"score":0.556050717830658},{"id":"https://openalex.org/C127078168","wikidata":"https://www.wikidata.org/wiki/Q138639","display_name":"Peroxisome","level":3,"score":0.5221610069274902},{"id":"https://openalex.org/C71240020","wikidata":"https://www.wikidata.org/wiki/Q186011","display_name":"Stereochemistry","level":1,"score":0.5107436180114746},{"id":"https://openalex.org/C2779485729","wikidata":"https://www.wikidata.org/wiki/Q210385","display_name":"Pyridine","level":2,"score":0.4897017776966095},{"id":"https://openalex.org/C2908929049","wikidata":"https://www.wikidata.org/wiki/Q65963433","display_name":"Angiotensin II","level":3,"score":0.48036250472068787},{"id":"https://openalex.org/C201194858","wikidata":"https://www.wikidata.org/wiki/Q898238","display_name":"Steric effects","level":2,"score":0.41571587324142456},{"id":"https://openalex.org/C21951064","wikidata":"https://www.wikidata.org/wiki/Q899212","display_name":"Combinatorial chemistry","level":1,"score":0.4068783223628998},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3816032409667969},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.36483192443847656},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.263283908367157},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.19013461470603943},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.17847546935081482},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15748777985572815},{"id":"https://openalex.org/C155647269","wikidata":"https://www.wikidata.org/wiki/Q243455","display_name":"Medicinal chemistry","level":1,"score":0.09085336327552795},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.07425227761268616},{"id":"https://openalex.org/C159110408","wikidata":"https://www.wikidata.org/wiki/Q121176","display_name":"Nursing","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D001665","descriptor_name":"Binding Sites","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D008958","descriptor_name":"Models, Molecular","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D008968","descriptor_name":"Molecular Conformation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011485","descriptor_name":"Protein Binding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D021281","descriptor_name":"Quantitative Structure-Activity Relationship","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D044140","descriptor_name":"Receptor, Angiotensin, Type 1","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D047228","descriptor_name":"Angiotensin II Type 1 Receptor Blockers","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D055672","descriptor_name":"Static Electricity","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D056004","descriptor_name":"Molecular Dynamics Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D062105","descriptor_name":"Molecular Docking Simulation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.18632/oncotarget.15778","doi":"https://doi.org/10.18632/oncotarget.15778","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.15778","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15778&path%5B%5D=51636","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},{"id":"pmid:28445965","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28445965","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:5421955","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC5421955/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.18632/oncotarget.15778","doi":"https://doi.org/10.18632/oncotarget.15778","is_oa":true,"landing_page_url":"https://doi.org/10.18632/oncotarget.15778","pdf_url":"http://www.oncotarget.com/index.php?journal=oncotarget&page=article&op=download&path%5B%5D=15778&path%5B%5D=51636","source":{"id":"https://openalex.org/S126644158","display_name":"Oncotarget","issn_l":"1949-2553","issn":["1949-2553"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","medline","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316297","host_organization_name":"Impact Journals LLC","host_organization_lineage":["https://openalex.org/P4310316297"],"host_organization_lineage_names":["Impact Journals LLC"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncotarget","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G2389767544","display_name":null,"funder_award_id":"Grant No. 21202120","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G4828270086","display_name":null,"funder_award_id":"81273361","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G5528875179","display_name":null,"funder_award_id":"21202120","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G6351589062","display_name":null,"funder_award_id":"81611130090","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"},{"id":"https://openalex.org/G7773384476","display_name":null,"funder_award_id":"2012T50237","funder_id":"https://openalex.org/F4320321543","funder_display_name":"China Postdoctoral Science Foundation"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"},{"id":"https://openalex.org/F4320321543","display_name":"China Postdoctoral Science Foundation","ror":"https://ror.org/0426zh255"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2592298658.pdf","grobid_xml":"https://content.openalex.org/works/W2592298658.grobid-xml"},"referenced_works_count":51,"referenced_works":["https://openalex.org/W616667036","https://openalex.org/W1226784152","https://openalex.org/W1573095123","https://openalex.org/W1622143472","https://openalex.org/W1816800410","https://openalex.org/W1821621537","https://openalex.org/W1896084606","https://openalex.org/W1943330482","https://openalex.org/W1951777410","https://openalex.org/W1972281547","https://openalex.org/W1976666288","https://openalex.org/W1985394876","https://openalex.org/W1999752412","https://openalex.org/W2000138008","https://openalex.org/W2003062823","https://openalex.org/W2003529979","https://openalex.org/W2007726502","https://openalex.org/W2009337598","https://openalex.org/W2010053993","https://openalex.org/W2010869459","https://openalex.org/W2052989449","https://openalex.org/W2055585711","https://openalex.org/W2057966202","https://openalex.org/W2058086874","https://openalex.org/W2071710249","https://openalex.org/W2075650012","https://openalex.org/W2080014646","https://openalex.org/W2085148761","https://openalex.org/W2090561555","https://openalex.org/W2100509895","https://openalex.org/W2108698393","https://openalex.org/W2110177837","https://openalex.org/W2114444511","https://openalex.org/W2118045012","https://openalex.org/W2120133441","https://openalex.org/W2127125241","https://openalex.org/W2129697991","https://openalex.org/W2150748501","https://openalex.org/W2173273216","https://openalex.org/W2183358035","https://openalex.org/W2194373590","https://openalex.org/W2217914754","https://openalex.org/W2254533201","https://openalex.org/W2257899469","https://openalex.org/W2268222020","https://openalex.org/W2286144089","https://openalex.org/W2286324767","https://openalex.org/W2411505974","https://openalex.org/W2414181230","https://openalex.org/W2415124586","https://openalex.org/W4236934136"],"related_works":["https://openalex.org/W1972281547","https://openalex.org/W2010053993","https://openalex.org/W6958509802","https://openalex.org/W2076390908","https://openalex.org/W2086152832","https://openalex.org/W1999752412","https://openalex.org/W2073516691","https://openalex.org/W1880253359","https://openalex.org/W2100874339","https://openalex.org/W2085148761"],"abstract_inverted_index":{"//":[0],"Jun":[1],"Zhang":[2],"1":[3,7,11,15,19,23,31,35,36,126],",":[4,8,12,16,20,24,28,32],"Qing-Qing":[5],"Hao":[6],"Xin":[9],"Liu":[10],"Zhi":[13],"Jing":[14],"Wen-Qing":[17],"Jia":[18],"Shu-Qing":[21],"Wang":[22,34],"Wei-Ren":[25],"Xu":[26],"2":[27,59,237,240,244,251,254,258],"Xian-Chao":[29,79],"Cheng":[30],"Run-Ling":[33,83],"Tianjin":[37,53,56,60,69,74],"Key":[38,61],"Laboratory":[39,62],"on":[40,196],"Technologies":[41],"Enabling":[42],"Development":[43],"of":[44,51,63,71,111,154,163,193,206,235,274],"Clinical":[45],"Therapeutics":[46],"and":[47,66,115,129,145,159,180,187,216,249,278,305,321],"Diagnostics":[48],"(Theranostics),":[49],"School":[50],"Pharmacy,":[52],"Medical":[54],"University,":[55],"300070,":[57],"China":[58,76],"Molecular":[64,228],"Design":[65],"Drug":[67],"Discovery,":[68],"Institute":[70],"Pharmaceutical":[72],"Research,":[73],"300193,":[75],"Correspondence":[77],"to:":[78],"Cheng,":[80],"email:":[81,85],"chengxianchao@aliyun.com":[82],"Wang,":[84],"wangrunling@tmu.edu.cn":[86],"Keywords:":[87],"imidazo-\\pyridines,":[88],"AT1,":[89],"PPAR\u03b3,":[90,262],"molecular":[91,185],"docking,":[92],"3D-QSAR":[93,188],"Received:":[94],"December":[95],"20,":[96],"2016":[97],"Accepted:":[98],"January":[99],"27,":[100],"2017":[101,105],"Published:":[102],"February":[103],"28,":[104],"ABSTRACT":[106],"Telmisartan,":[107],"a":[108],"bifunctional":[109],"agent":[110],"blood":[112],"pressure":[113],"lowering":[114],"glycemia":[116],"reduction,":[117],"was":[118],"previously":[119],"reported":[120],"to":[121,141],"antagonize":[122],"angiotensin":[123],"II":[124],"type":[125],"(AT1)":[127],"receptor":[128,134,179],"partially":[130],"activate":[131],"peroxisome":[132],"proliferator-activated":[133],"\u03b3":[135],"(PPAR\u03b3)":[136],"simultaneously.":[137],"Through":[138],"the":[139,150,173,177,182,221,268,282,286,289],"modification":[140],"telmisartan,":[142],"researchers":[143],"designed":[144,296],"obtained":[146],"imidazo-\\pyridine":[147],"derivatives":[148,208],"with":[149,176,209,220,288,299],"IC":[151],"50":[152,161],"s":[153,162],"0.49~94.1":[155],"nM":[156,165],"against":[157],"AT1":[158,248,304,319],"EC":[160],"20~3640":[164],"towards":[166,281,303],"PPAR\u03b3":[167,306,323],"partial":[168,307,322],"activation.":[169,308],"For":[170],"minutely":[171],"inquiring":[172],"interaction":[174,214],"modes":[175],"relevant":[178],"analyzing":[181],"structure-activity":[183,190],"relationships,":[184],"docking":[186],"(Quantitative":[189],"relationships)":[191],"analysis":[192],"these":[194,207,310],"imidazo-\\pyridines":[195],"dual":[197,318],"targets":[198],"were":[199],"conducted":[200],"in":[201],"this":[202],"work.":[203],"Docking":[204],"approaches":[205],"both":[210],"receptors":[211],"provided":[212],"explicit":[213],"behaviors":[215],"excellent":[217],"matching":[218],"degree":[219],"binding":[222],"pockets.":[223],"The":[224,264],"best":[225],"CoMFA":[226],"(Comparative":[227],"Field":[229],"Analysis)":[230],"models":[231],"exhibited":[232],"predictive":[233],"results":[234,311],"q":[236,250],"=0.553,":[238],"r":[239,243,253,257],"=0.954,":[241],"SEE=0.127,":[242],"pred":[245,259],"=0.779":[246],"for":[247,261,315],"=0.503,":[252],"=1.00,":[255],"SEE=0.019,":[256],"=0.604":[260],"respectively.":[263],"contour":[265],"maps":[266],"from":[267,292],"optimal":[269],"model":[270],"showed":[271],"detailed":[272],"information":[273,291],"structural":[275],"features":[276],"(steric":[277],"electrostatic":[279],"fields)":[280],"biological":[283],"activity.":[284],"Combining":[285],"bioisosterism":[287],"valuable":[290],"above":[293],"studies,":[294],"we":[295],"six":[297],"molecules":[298],"better":[300],"predicted":[301],"activities":[302],"Overall,":[309],"could":[312],"be":[313],"useful":[314],"designing":[316],"potential":[317],"antagonists":[320],"agonists.":[324]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2017-03-16T00:00:00"}